Affirm Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Affirm Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.22B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $2.32B | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $1.59B | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $1.35B | Aug 28, 2024 |
| FY2023 | Jun 30, 2021 | $870.46M | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | $509.53M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $264.37M | Sep 17, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.11B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $826.01M | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $626.94M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $559.21M | Aug 28, 2024 |
| FY2023 | Jun 30, 2021 | $429.40M | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | $276.09M | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | $140.27M | Sep 17, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $52.19M | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | ($517.76M) | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | ($985.35M) | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | ($707.42M) | Aug 28, 2024 |
| FY2023 | Jun 30, 2021 | ($441.03M) | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | ($112.60M) | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | ($120.46M) | Sep 17, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($87.27M) | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | ($615.85M) | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | ($1.20B) | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | ($866.05M) | Aug 28, 2024 |
| FY2023 | Jun 30, 2021 | ($383.67M) | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | ($107.79M) | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | ($127.44M) | Sep 17, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $11.15B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $9.52B | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $8.16B | Aug 28, 2024 |
| FY2023 | Jun 30, 2022 | $6.97B | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $4.87B | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $1.40B | Sep 17, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $8.09B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $6.79B | Aug 28, 2025 |
| FY2024 | Jun 30, 2023 | $5.62B | Aug 28, 2024 |
| FY2023 | Jun 30, 2022 | $4.36B | Aug 25, 2023 |
| FY2022 | Jun 30, 2021 | $2.29B | Aug 29, 2022 |
| FY2021 | Jun 30, 2020 | $965.18M | Sep 17, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.07B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $2.73B | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $2.53B | Aug 28, 2025 |
| FY2025 | Jun 30, 2022 | $2.62B | Aug 28, 2025 |
| FY2024 | Jun 30, 2021 | $2.58B | Aug 28, 2024 |
| FY2023 | Jun 30, 2020 | ($367.10M) | Aug 25, 2023 |
| FY2022 | Jun 30, 2019 | ($263.41M) | Aug 29, 2022 |
| FY2021 | Jun 30, 2018 | ($169.27M) | Sep 17, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | (1) | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | (3) | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | (2) | Aug 28, 2024 |
| FY2023 | Jun 30, 2021 | (2) | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | (2) | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | (2) | Sep 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | (1) | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | (3) | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | (2) | Aug 28, 2024 |
| FY2023 | Jun 30, 2021 | (2) | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | (2) | Aug 29, 2022 |
| FY2021 | Jun 30, 2019 | (2) | Sep 17, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.35B | Aug 28, 2025 |
| FY2025 | Jun 30, 2024 | $1.01B | Aug 28, 2025 |
| FY2025 | Jun 30, 2023 | $892.03M | Aug 28, 2025 |
| FY2024 | Jun 30, 2022 | $1.26B | Aug 28, 2024 |
| FY2023 | Jun 30, 2021 | $1.47B | Aug 25, 2023 |
| FY2022 | Jun 30, 2020 | $267.06M | Aug 29, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.61B | Aug 28, 2025 |
| FY2024 | Jun 30, 2024 | $1.84B | Aug 28, 2024 |